8 research outputs found

    Internuclear interaction and distortion effects on fully differential cross section for single ionization of helium by 100 MeV/amu C

    No full text
    The modified Coulomb-Born approximation model is applied to calculate the fully differential cross section (FDCS) for single ionization of helium by 100 MeV/amu C6+ impact. We study the influence of the internuclear interaction on the FDCS in the scattering plane and the perpendicular plane. Comparisons are made with absolute experimental data and the 3DW results and we find that our calculations with (without) the internuclear interaction yield excellent agreement with experiments for the small (large) momentum transfer. Accordingly, we discuss the contributions of distortion effects to the FDCS both in the scattering plane and the perpendicular plane. It turns out that the distortion effects become significantly important with increasing momentum transfer

    Revisiting the recollisional ( e

    No full text

    Patients with Asian-type DEL can safely be transfused using RhD-positive blood

    No full text
    Red blood cells (RBCs) of the Asian-type DEL phenotype express few RhD proteins and are typed as serologic RhD-negative (D-) in routine testing. RhD-positive (D+) RBC transfusion for Asian-type DEL patients has been proposed but has not been generally adopted due to a lack of direct evidence regarding its safety and underlying mechanism. We performed a single-arm multicenter clinical trial to document the outcome of D+ RBC transfusion in Asian-type DEL patients; none of the recipients (0/42; 95% confidence interval, 0%-8.40%) developed alloanti-D after a median follow-up of 226 days. We conducted a large retrospective study to detect alloanti-D immunization in 4,045 serologic D- pregnant women throughout China; alloanti-D was found only in true D- individuals (2.63%, 79/3,009), but not in those with Asian-type DEL (0/1,032). We further retrospectively examined 127 serologic D- pregnant women who had developed alloanti-D and found none with Asian-type DEL (0/127). Finally, we analyzed RHD transcripts from Asian-type DEL erythroblasts and examined antigen epitopes expressed by various RHD transcripts in vitro, finding a low abundance of full-length RHD transcripts (0.18% of the total) expressing RhD antigens carrying the entire repertoire of epitopes, which could explain the immune tolerance against D+ RBCs. Our results provide multiple lines of evidence that individuals with Asian-type DEL cannot produce alloanti-D when exposed to D+ RBCs following transfusion or pregnancy. Therefore, we recommend considering D+ RBC transfusion and discontinuing anti-D prophylaxis in Asian-type DEL patients, including pregnant women. This clinical trial is registered at www.clinicaltrials.gov as NCT03727230
    corecore